An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib.
Saved in:
| Title: | An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib. |
|---|---|
| Authors: | Sooi, Kenneth1 (AUTHOR), Danchaivijtr, Pongwut2 (AUTHOR), Wong, C. K.3 (AUTHOR), Tu, V. D.4 (AUTHOR), Sachdeva, Manavi1 (AUTHOR), Tai, B. C.5 (AUTHOR), Soo, Ross A.1 (AUTHOR) ross_soo@nuhs.edu.sg |
| Source: | Thoracic Cancer. Jul2026, Vol. 17 Issue 13, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17597706 |
|---|---|
| DOI: | 10.1111/1759-7714.70331 |
